Hot Features
Rebus Holdings, Inc., together with its subsidiaries, focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. Rebus Hold... Rebus Holdings, Inc., together with its subsidiaries, focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. Rebus Holdings, Inc. was incorporated in 2003 and is based in Westlake Village, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 30000 | 0.0001 | CS |
| 12 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 10138 | 9.729E-5 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 6951 | 9.776E-5 | CS |
| 52 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 35067 | 9.379E-5 | CS |
| 156 | -0.01439 | -99.3098688751 | 0.01449 | 0.02 | 1.0E-6 | 75276 | 0.00418711 | CS |
| 260 | -0.0998 | -99.8998998999 | 0.0999 | 0.12 | 1.0E-6 | 228374 | 0.02219058 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.